About Advanced Cell Technology
Advanced Cell Technology is a publicly listed company based in Worcester (United States) founded in 1994. It operates as a stem-cell-based treatments for regenerative medicine are developed using advanced techniques. Its chief executive is Ray L Parvin. Advanced Cell Technology offers products and services including Nuclear Transfer Technology, Blastomere Program, and RPE Program. Its focus areas include Life Sciences, Cell Therapy, Stem Cells and Progenitor Cells. Its legal entity is Advanced Cell Technology, Inc. Its competitors include Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Advanced Cell Technology was founded in 1994 in Worcester, United States, and operates in the regenerative medicine sector. Stem cell techniques, including embryonic and hematopoietic stem cells, are utilized to develop treatments for conditions such as macular degeneration and retinal pigment layer implantation. The companys efforts focus on creating therapeutic options through these biological methods, led by CEO Ray L Parvin.
- Headquarters Worcester, United States
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website advancedcell.com
- Social YouTube
- Legal Name Advanced Cell Technology, Inc.
- Latest Funding Round$25M (USD), Unspecified
Jan 2011
Products & Services of Advanced Cell Technology
Advanced Cell Technology offers a comprehensive portfolio of products and services, including Nuclear Transfer Technology, Blastomere Program, and RPE Program.
Technology for producing genetically matched cells to treat diseases.
Program focused on early-stage cell development for medical applications.
Initiative for retinal pigment epithelium cell regeneration in eye disorders.
Apps and channels of Advanced Cell Technology
its YouTube channel Ocata Therapeutics has 80 subscribers and 3 videos.
Videos from Advanced Cell Technology
The most watched videos on Advanced Cell Technology's YouTube channel, Ocata Therapeutics (80 subscribers). Click a video to play it here.
More on Ocata Therapeutics.
Funding Insights of Advanced Cell Technology
- Total Rounds 2
- Last Round Unspecified — $25M
- First Round $2.78M
(Nov 2009)
All 2 funding rounds of Advanced Cell Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2011 | $25M | Unspecified | – | – | – |
| Nov 2009 | $2.78M | Debt – Conventional | – | – | – |
People of Advanced Cell Technology
1 people are tracked at Advanced Cell Technology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ray L Parvin | CEO | Leadership |
Complete people profiles for Advanced Cell Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Advanced Cell Technology
3 dated milestones of Advanced Cell Technology across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Advanced Cell Technology is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Unspecified, of $25.0M.
Competitors of Advanced Cell Technology
Advanced Cell Technology has 8 listed competitors in our database, 6 of them funded. They include Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| annexonbio.com | 2011 | San Francisco, United States | $256M | 80 | Developer of antibodies to treat complement-mediated neurodegenerative diseases | |
| aldeyra.com | 2004 | Lexington, United States | $4.79M | 30 | Drug candidates for immune-mediated diseases are developed by Aldeyra. | |
| nicox.com | 1996 | Valbonne, France | $271.01M | – | Nitric oxide-based therapeutics for glaucoma and eye conditions are developed. | |
| gyroscope.cc | 2016 | San Francisco, United States | – | – | Mobile SDK developed for app engagement and monetization strategies. | |
| meiragtx.com | 2015 | New York, United States | – | 358 | Gene therapies for ocular and neurodegenerative diseases are developed. | |
| jaspertx.com | 1999 | Redwood, United States | $84.1M | – | Developer of therapeutics for chronic diseases by targeting mast cells and stem cells | |
| kiadis.com | 1997 | Amsterdam, Netherlands | $32.95M | – | Therapeutic solutions for hematopoietic stem cell transplants are developed. | |
| alimerasciences.com | 2003 | Alpharetta, United States | $66.8M | 79 | Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. |
Detailed competitors of Advanced Cell Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Advanced Cell Technology
The website of Advanced Cell Technology (advancedcell.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 21.1% vs previous month
Websites whose visitors overlap most with Advanced Cell Technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| viacellinc.com | 100% | – | – | View details | |
| the-scientist.com | 96% | 333.7K | #165,042 | View details | |
| stemcellsinc.com | 91% | – | – | View details | |
| stemcell.com | 77% | 262.4K | #179,047 | View details | |
rocklandschools.org | rocklandschools.org | 57% | – | #4,963,362 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Advanced Cell Technology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
10 companies that operate in the same segment as Advanced Cell Technology (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 253 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Advanced Cell Technology
Complete news archive for Advanced Cell Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advanced Cell Technology
Advanced Cell Technology was founded in 1994 and raised its 1st funding round 15 years after it was founded.
Advanced Cell Technology is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
Ray L Parvin is the current CEO of Advanced Cell Technology.
Advanced Cell Technology was founded in 1994 in Worcester, United States, and operates in the regenerative medicine sector. Stem cell techniques, including embryonic and hematopoietic stem cells, are utilized to develop treatments for conditions such as macular degeneration and retinal pigment layer implantation. The companys efforts focus on creating therapeutic options through these biological methods, led by CEO Ray L Parvin.
Advanced Cell Technology's top competitors include Annexon, Alimera Sciences and MeiraGTx.
Advanced Cell Technology offers Nuclear Transfer Technology, Blastomere Program, and RPE Program.
Advanced Cell Technology operates through Advanced Cell Technology, Inc..